Deutsche Bank Ag\ Aprea Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 04, 2021	SELL	$3.43 - $5.63 $323,743 - $531,393	-94,386 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$4.05 - $5.5 $7,261 - $9,861	1,793 Added 1.94%	94,386 $461,000
Q1 2021 May 13, 2021	BUY	$4.73 - $8.15 $411,358 - $708,789	86,968 Added 1546.1%	92,593 $472,000
Q4 2020 Feb 16, 2021	BUY	$4.92 - $30.67 $8,634 - $53,825	1,755 Added 45.35%	5,625 $27,000
Q3 2020 Nov 12, 2020	BUY	$21.66 - $38.86 $7,624 - $13,678	352 Added 10.01%	3,870 $93,000
Q2 2020 Aug 13, 2020	BUY	$25.47 - $39.69 $32,576 - $50,763	1,279 Added 57.12%	3,518 $136,000
Q1 2020 May 14, 2020	SELL	$31.65 - $45.3 $4,177 - $5,979	-132 Reduced 5.57%	2,239 $78,000
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $44,906 - $117,435	2,371 New	2,371 $108,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,589
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.